EISAI INC.
bd_ae4fadfa5a009c4b · schema v1 · pii pii-v1
Full breach record for EISAI INC. →Threat-actor claim — not a regulatory filing
This row is a claim by the ransomware group Atomsilo on its public extortion blog. It has not been validated by the victim or any regulator. Treat attribution and counts as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.
Source: Ransomware.live
Post text · scraped from the leak site
Eisai Co., Ltd. is a Japanese multinational pharmaceutical company headquartered in Tokyo. Established in 1941, it's one of the leading firms in the field of neurology and oncology. Eisai produces several drugs used globally such as Aricept for Alzheimer's disease and Halaven for breast cancer. Aside from drug creation, Eisai also engages in global health initiatives.
Source provenance
- Source URL
- https://www.ransomware.live/
DisclosureLens links to the originating regulator URL — full filing bodies are not redistributed from public surfaces (§4.5).
- Filed at
- Dec 21, 2021
- Raw hash
- 409c349a086c53a41bcf23e3bc7d7ed7bc32c377f6ffdb82813eebe0cabc8c3e
Reporting entity
- Name
- atomsilo
Victim entity
- Name
- EISAI INC.norm: eisai
- Domain
- eisai.com
- Industry
- Healthcare
What this source establishes
- Source ceiling
- A leak-site claim can't tell us: discovery date · materiality · notification · affected count · confirmed data types · compliance clock. These stay blank until a regulatory filing or victim disclosure lands.
- Attack vector
- Ransomware· atomsilo
- Threat actor
- AtomsiloExternalFinancial
Compliance
- Compliance flags
- — (clock not assessable for this source)
Extraction provenance
- Status
- No extraction artifact recorded for this disclosure.